The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167
Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery
Polli, J. W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O., & Serabjit-Singh, C. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29270-3 · Cited by 662
Cisternino, S., Mercier, C., Bourasset, F., Roux, F., & Scherrmann, J.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2033 · Cited by 329
Uhr, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00095-0 · Cited by 244
Yamazaki, M., Neway, W. E., Ohe, T., Chen, I.-W., Rowe, J. F., Hochman, J. H., Chiba, M., & Lin, J. H. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38809-3 · Cited by 238
Goadsby, P. J. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00010-1 · Cited by 237
Uhr, M., Grauer, M. T., & Holsboer, F. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00074-x · Cited by 237
P-Glycoprotein Limits the Brain Penetration of Nonsedating but not Sedating H1-Antagonists
Chen, C., Hanson, E., Watson, J. W., & Lee, J. S. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.3.312 · Cited by 227
Self-citationVariable modulation of opioid brain uptake by P-glycoprotein in mice
Dagenais, C., Graff, C. L., & Pollack, G. M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.027 · Cited by 220
Maurer, T. S., DeBartolo, D. B., Tess, D. A., & Scott, D. O. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001222 · Cited by 214
Dagenais, C., Rousselle, C., Pollack, G. M., & Scherrmann, J.-M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200002000-00020 · Cited by 202
Hendrikse, N. H., Schinkel, A. H., De Vries, E. G. E., Fluks, E., Van der Graaf, W. T. A., Willemsen, A. T. M., Vaalburg, W., & Franssen, E. J. F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701979 · Cited by 182
Huang, S.-M. (2004) · Applications of Pharmacokinetic Principles in Drug Development · doi:10.1007/978-1-4419-9216-1_10 · Cited by 181
MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin
Roulet, A., Puel, O., Gesta, S., Lepage, J.-F., Drag, M., Soll, M., Alvinerie, M., & Pineau, T. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02955-2 · Cited by 171
Letrent, S. P., Pollack, G. M., Brouwer, K. R., & Brouwer, K. L. R. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)11822-3 · Cited by 169
Kapur, S., Langlois, X., Vinken, P., Megens, A. A. H. P., De Coster, R., & Andrews, J. S. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035303 · Cited by 158
The Problem of Non-compliance with Drug Therapy
Evans, L., & Spelman, M. S. (1983) · Drugs · doi:10.2165/00003495-198325010-00004 · Cited by 142
Uhr, M., & Grauer, M. T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00022-0 · Cited by 126
Disposition of Ivermectin and Cyclosporin A in CF-1 Mice Deficient in mdr1a P-Glycoprotein
Kwei, G. Y., Alvaro, R. F., Chen, Q., Jenkins, H. J., Hop, C. E. C. A., Keohane, C. A., Ly, V. T., Strauss, J. R., Wang, R. W., Wang, Z., et al. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15253-1 · Cited by 124
Self-citationIncreased brain P-glycoprotein in morphine tolerant rats
Aquilante, C. L., Letrent, S. P., Pollack, G. M., & Brouwer, K. L. R. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00599-8 · Cited by 117
Midazolam Exhibits Characteristics of a Highly Permeable P-Glycoprotein Substrate
Tolle‐Sander, S., Rautio, J., Wring, S., Polli, J. W., & Polli, J. E. (2003) · Pharmaceutical Research · doi:10.1023/a:1023433502647 · Cited by 81
Optimizing Limbic Selective D2/D3 Receptor Occupancy by Risperidone: A [123I]-Epidepride SPET Study
Bressan, R. A., Erlandsson, K., JONES, H. M., Mulligan, R. S., Ell, P. J., & Pilowsky, L. S. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00002 · Cited by 79
Nitric oxide and biopterin in depression and stress
van Amsterdam, J., & Opperhuizen, A. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(98)00140-1 · Cited by 66
Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia.
Lavalaye, J., Linszen, D., Booij, J., Reneman, L., Gersons, B., & van Royen, E. V. (1999) · Psychiatry Research · doi:10.1016/s0925-4927(99)00032-3 · Cited by 47
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
Structure−Brain Exposure Relationships
Hitchcock, S. A., & Pennington, L. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060642i · Cited by 698
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 617
Metadata
- Authors
- Doran, A., Obach, R. S., Smith, B. J., Hosea, N. A., Becker, S., Callegari, E., Chen, C., Chen, X., Choo, E., Cianfrogna, J., Cox, L. M., Gibbs, J. P., Gibbs, M. A., Hatch, H., Hop, C. E. C. A., Kasman, I. N., LaPerle, J., Liu, J., Liu, X., Logman, M., Maclin, D., Nedza, F. M., Nelson, F., Olson, E., Rahematpura, S., Raunig, D., Rogers, S., Schmidt, K., Spracklin, D. K., Szewc, M., Troutman, M., Tseng, E., Tu, M., Van Deusen, J. W., Venkatakrishnan, K., Walens, G., Wang, E. Q., Wong, D., Yasgar, A. S., & Zhang, C.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 33
- Issue
- 1
- Pages
- 165-174
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2108141803
- Cited by
- 443
- References
- 26
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.